Byron J. Hoogwerf, MD, CDE

Professor of Medicine
Division of Endocrinology
Department of Internal Medicine
Cleveland Clinic Foundation Health Services Center
Ohio State University
Director Internal Medicine Residency Program
Cleveland Clinic Foundation
Cleveland, Ohio

Byron J. Hoogwerf, MD is a staff physician in the Department of Endocrinology at the Cleveland Clinic Foundation, serves as director of the internal medicine residency program, and is a member of the Preventive Cardiology Clinic staff. Dr. Hoogwerf earned his medical degree from the University of Minnesota Medical School, and completed his residency and endocrinology fellowship training at the University of Minnesota and the Hennepin County Medical Center. He spent four years on the faculty of the University of Minnesota before moving to the Cleveland Clinic in 1985. He has academic appointments as professor of medicine at the Cleveland Clinic Health Services Center of the Ohio State University and as clinical professor of medicine at Penn State University.

Dr. Hoogwerf is past president of the Diabetes Association of Greater Cleveland and is active with American Diabetes Association (ADA) including past membership on the Minnesota and Ohio affiliate boards, the Professional Practice Committee, has served as chair of the Council on Nutritional Sciences and Metabolism, and a member of the 1994 Nutrition Guidelines Task Force and the 2002 Nutrition Guidelines writing group. He was a member of the ADA national board from 1998-2001, chair of the ADA Publications Policy Committee from 2000-2002 and a current member of the Physician Recognition Committee.

He is a fellow of the American College of Physicians, a member of The Endocrine Society, a charter member of American Association of Clinical Endocrinologists, and a fellow of the American College of Endocrinology.

Dr. Hoogwerf’s clinical and research interests are diabetes mellitus and lipid disorders. He has more than 100 published articles and book chapters. He has been actively involved in several large multi-center clinical trials including the LRC-CPPT, DCCT (pilot phase), ETDRS, Post CABG, HOPE, HOPE-TOO, ACCORD, DREAM and OnTARGET/TRANSCEND.